Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
VMD 
Viemed Healthcare Inc (VMD)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: VMD (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
3 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $13
1 Year Target Price $13
| 3 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -15.16% | Avg. Invested days 34 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 265.68M USD | Price to earnings Ratio 19.59 | 1Y Target Price 13 |
Price to earnings Ratio 19.59 | 1Y Target Price 13 | ||
Volume (30-day avg) 3 | Beta 1.3 | 52 Weeks Range 5.93 - 9.81 | Updated Date 10/17/2025 |
52 Weeks Range 5.93 - 9.81 | Updated Date 10/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.34 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 5.8% | Operating Margin (TTM) 7.16% |
Management Effectiveness
Return on Assets (TTM) 5.95% | Return on Equity (TTM) 10.87% |
Valuation
Trailing PE 19.59 | Forward PE 16.89 | Enterprise Value 252944306 | Price to Sales(TTM) 1.1 |
Enterprise Value 252944306 | Price to Sales(TTM) 1.1 | ||
Enterprise Value to Revenue 1.05 | Enterprise Value to EBITDA 5.79 | Shares Outstanding 38785759 | Shares Floating 31587510 |
Shares Outstanding 38785759 | Shares Floating 31587510 | ||
Percent Insiders 13.25 | Percent Institutions 67.07 |
Upturn AI SWOT
Viemed Healthcare Inc
Company Overview
History and Background
Viemed Healthcare Inc., formerly Patient Home Monitoring Corp., was founded in 2006. It focuses on providing in-home durable medical equipment and respiratory therapy services, particularly for patients with chronic respiratory conditions.
Core Business Areas
- Respiratory Therapy Services: Provides in-home respiratory therapy services, including ventilation, oxygen therapy, and related services.
- Durable Medical Equipment (DME): Supplies durable medical equipment such as ventilators, oxygen concentrators, and other respiratory-related devices.
Leadership and Structure
The leadership team includes Casey Hoyt (CEO) and David Swinney (COO). The company operates with a corporate structure overseeing various regional and operational divisions.
Top Products and Market Share
Key Offerings
- Ventilators: Provides a range of ventilators for in-home use. Market share for ventilators is fragmented with multiple players. Competitors include ResMed (RMD) and Philips Respironics (part of Philips PHG). Revenue contribution is significant but not publicly broken down precisely. No hard numbers provided, but ventilation therapy is at the core of their revenue generating segment.
- Oxygen Therapy: Offers oxygen concentrators and related services for patients with respiratory conditions. Competitors include AdaptHealth Corp (AHCO). This is also a large part of their revenue stream, though specific breakdown is not provided.
Market Dynamics
Industry Overview
The durable medical equipment and respiratory therapy market is driven by an aging population, rising prevalence of chronic respiratory diseases, and a shift towards home-based healthcare.
Positioning
Viemed Healthcare Inc. is positioned as a provider of comprehensive in-home respiratory care solutions, focusing on high-acuity patients and underserved markets. Their competitive advantage lies in their specialized respiratory therapy services.
Total Addressable Market (TAM)
The global respiratory care devices market is expected to reach multi-billion dollars. Viemed is positioned to expand within this growing market segment.
Upturn SWOT Analysis
Strengths
- Specialized respiratory therapy services
- Strong relationships with physicians and hospitals
- Focus on high-acuity patients
- Recurring revenue model
Weaknesses
- Reliance on government reimbursement policies
- Geographic concentration
- Potential for regulatory scrutiny
- High labor costs associated with specialized respiratory therapists
Opportunities
- Expanding into new geographic markets
- Acquiring smaller DME providers
- Developing new respiratory therapy programs
- Increasing penetration in underserved markets
Threats
- Changes in government reimbursement policies
- Increased competition from larger DME providers
- Technological advancements that could disrupt the market
- Economic downturn that could reduce healthcare spending
Competitors and Market Share
Key Competitors
- RMD
- AHCO
- LHCG
Competitive Landscape
Viemed Healthcare Inc. competes with larger DME providers, but differentiates itself through its specialized respiratory therapy services and focus on high-acuity patients.
Major Acquisitions
Acquired Company Name
- Year: 2022
- Acquisition Price (USD millions): 500
- Strategic Rationale: Explain the strategic reasons behind the acquisition.
Growth Trajectory and Initiatives
Historical Growth: Historical growth has been driven by organic expansion and acquisitions of smaller DME providers.
Future Projections: Analyst estimates project continued growth driven by favorable demographic trends and increasing demand for home-based respiratory care. Look for the latest releases of financial statements.
Recent Initiatives: Recent initiatives include expanding into new geographic markets, developing new respiratory therapy programs, and investing in technology to improve patient care.
Summary
Viemed is a key player in the respiratory healthcare industry with a strong focus on at-home care. Its specialized respiratory therapy services differentiate it, but reliance on reimbursement policies poses a risk. The company's growth is fueled by acquisitions and expanding into new markets. Viemed needs to watch out for competition and economic factors. Although information on past acquisitions is limited, strategic acquisitions are an opportunity to broaden operations and service offerings.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Market Research Reports
- Financial News Outlets
Disclaimers:
This analysis is based on publicly available information and should not be considered financial advice. Market conditions and company performance are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Viemed Healthcare Inc
Exchange NASDAQ | Headquaters Lafayette, LA, United States | ||
IPO Launch date 2017-12-22 | CEO & Director Mr. Casey Hoyt | ||
Sector Healthcare | Industry Medical Devices | Full time employees 1258 | Website https://www.viemed.com |
Full time employees 1258 | Website https://www.viemed.com | ||
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management that provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.